Great Lakes NeuroTechnologies

Great Lakes NeuroTechnologies is a private, revenue-generating medical device company specializing in digital biomarkers and remote monitoring for neurological conditions, particularly movement disorders. The company has established a commercial product line, Kinesia, which is used in clinical care, deep brain stimulation (DBS) management, and as an objective endpoint in global clinical trials. Its growth is supported by NIH SBIR grants and a growing patent portfolio covering AI-driven symptom measurement and treatment adjustment, positioning it at the intersection of neurology, telemedicine, and decentralized clinical trials.

Wearable bioinstrumentation platform integrating motion sensors, wireless data transmission, and cloud-based AI analytics for objective measurement of physiological and motor symptoms.

GLNT competes in the digital neurology and wearable sensor space against companies like MC10 (now part of Medidata), Rune Labs, and academic spin-offs. It differentiates itself with FDA-cleared devices, a strong publication record, and a specific focus on quantitative motor assessment for clinical and research use.